The Human Estrogen Receptor-α Is a Ubiquitinated Protein Whose Stability Is Affected Differentially by Agonists, Antagonists, and Selective Estrogen Receptor Modulators

作者: Ashini L. Wijayaratne , Donald P. McDonnell

DOI: 10.1074/JBC.M101097200

关键词:

摘要: The human estrogen receptor alpha-isoform (ERalpha) is a nuclear transcription factor that displays complex pharmacology. In addition to classical agonists and antagonists, the transcriptional activity of ERalpha can be regulated by selective modulators, new class drugs whose relative agonist/antagonist determined cell context. It has been demonstrated binding different ligands results in formation unique ERalpha-ligand conformations. These conformations have shown influence ERalpha-cofactor and, therefore, profound impact on this study, we demonstrate nature bound ligand also influences stability ERalpha, revealing an additional mechanism which pharmacological compound determined. Of note found although all complexes ubiquitinated degraded 26 S proteasome vivo, mechanisms they are targeted for proteolysis appear different. Specifically, agonist-activated inverse relationship between was observed. This does not extend modulators pure antagonists. Instead, it appears with these compounds, determinant ligand-induced conformation ERalpha. We conclude conformational states adopted presence directly regulating cofactor indirectly modulating stability.

参考文章(58)
S L Dana, P A Hoener, D A Wheeler, C B Lawrence, D P McDonnell, Novel estrogen response elements identified by genetic selection in yeast are differentially responsive to estrogens and antiestrogens in mammalian cells. Molecular Endocrinology. ,vol. 8, pp. 1193- 1207 ,(1994) , 10.1210/MEND.8.9.7838152
J M Beekman, G F Allan, S Y Tsai, M J Tsai, B W O'Malley, Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain. Molecular Endocrinology. ,vol. 7, pp. 1266- 1274 ,(1993) , 10.1210/MEND.7.10.8264659
J. Zhang, M. G. Guenther, R. W. Carthew, M. A. Lazar, Proteasomal regulation of nuclear receptor corepressor-mediated repression. Genes & Development. ,vol. 12, pp. 1775- 1780 ,(1998) , 10.1101/GAD.12.12.1775
A. Howell, D.J. DeFriend, R.W. Blamey, J.F. Robertson, P. Walton, Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer The Lancet. ,vol. 345, pp. 29- 30 ,(1995) , 10.1016/S0140-6736(95)91156-1
David M Lonard, Zafar Nawaz, Carolyn L Smith, Bert W O'Malley, The 26S Proteasome Is Required for Estrogen Receptor-α and Coactivator Turnover and for Efficient Estrogen Receptor-α Transactivation Molecular Cell. ,vol. 5, pp. 939- 948 ,(2000) , 10.1016/S1097-2765(00)80259-2
Jae Woon Lee, Fergus Ryan, Jonathan C Swaffield, Stephen A Johnston, David D Moore, None, Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature. ,vol. 374, pp. 91- 94 ,(1995) , 10.1038/374091A0
Ashini L. Wijayaratne, Susan C. Nagel, Lisa A. Paige, Dale J. Christensen, John D. Norris, Dana M. Fowlkes, Donald P. McDonnell, Comparative analyses of mechanistic differences among antiestrogens. Endocrinology. ,vol. 140, pp. 5828- 5840 ,(1999) , 10.1210/ENDO.140.12.7164
Abdelhamid El Khissiin, Guy Leclercq, Implication of proteasome in estrogen receptor degradation. FEBS Letters. ,vol. 448, pp. 160- 166 ,(1999) , 10.1016/S0014-5793(99)00343-9